Market Research Report
Nebulizer Market Research Report: By Product Type, Portability, Application, End User - Global Industry Analysis and Growth Forecast to 2030
|Nebulizer Market Research Report: By Product Type, Portability, Application, End User - Global Industry Analysis and Growth Forecast to 2030|
Published: September 1, 2020
Prescient & Strategic Intelligence Private Limited
Content info: 199 Pages
Delivery time: 2-3 business days
Nebulizer Market Research Report: By Product Type (Pneumatic, Ultrasonic, Mesh), Portability (Portable, Stand-Alone), Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis), End User (Hospitals and Ambulatory Surgical Centers, Emergency Centers) - Global Industry Analysis and Growth Forecast to 2030.
Within less than a year of being detected in December 2019, the novel coronavirus (COVID-19) had infected more than 38 million and killed over a million people till mid-October 2020, and both these counts are rising with every passing day. This has crippled the global healthcare sector, with inventories of everything, from testing kits and syringes to beds and ventilators, depleting fast. Thus, governments are making an all-out effort to procure all the necessary stuff to make patients comfortable and treat them.
As per P&S Intelligence, due to the havoc being wreaked by the COVID-19 pandemic, the nebulizer market will witness steady growth, from $765.1 million in 2019 to $1,698.1 million by 2030, at a 7.4% CAGR between 2020 and 2030. Nebulizers are used to aerosolize medication, so that it can be delivered straight into the lungs, via the nose. There are three main types of nebulizers available: mesh, pneumatic, and ultrasonic, among which people are most likely to be treated with a pneumatic variant.
These devices have been popular since long before the coronavirus pandemic began, as the prevalence of several other respiratory diseases has been high forever. For instance, as per the World Health Organization (WHO), more than 235 million people on the planet live with asthma, which is vastly common in children. Similarly, 3 million people die of chronic obstructive pulmonary disease (COPD) each year. Additionally, every year, 2.09 million cases of lung cancer are registered.
In the years to come, the fastest growth in the nebulizer market is set to be witnessed in the Asia-Pacific (APAC) region. Regional cities are some of the most polluted on earth, with an air quality index (AQI) of more than 200 becoming an almost-everyday occurrence in Delhi. Furthermore, as per the WHO, more than 70% of COPD deaths take place in low- and middle-income countries, a lot of which are in APAC. To make matters worse, India, China, and Japan are home to a large population of smokers, which also increases the prevalence of respiratory diseases.
Therefore, with the increasing cases of COVID-19 and other lung diseases, the demand for nebulizers will pick up.